Asset Allocation

As of October 31, 2025.
Type % Net
Cash 0.44%
Stock 58.37%
Bond 33.40%
Convertible 0.00%
Preferred 8.30%
Other -0.51%
View Asset Allocation
Start Trial

Market Capitalization

As of October 31, 2025
Large 93.41%
Mid 4.50%
Small 2.09%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 99.65%    % Emerging Markets: 0.16%    % Unidentified Markets: 0.19%

Americas 97.75%
97.25%
Canada 84.68%
United States 12.57%
0.50%
Mexico 0.00%
As of October 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 1.82%
United Kingdom 0.65%
1.17%
France 0.14%
Germany 0.17%
Ireland 0.68%
Netherlands 0.01%
Spain 0.11%
Switzerland 0.00%
0.00%
0.00%
Greater Asia 0.25%
Japan 0.01%
0.23%
Australia 0.23%
0.01%
Singapore 0.01%
0.00%
Unidentified Region 0.19%

Bond Credit Quality Exposure

AAA 29.00%
AA 11.84%
A 15.94%
BBB 20.12%
BB 5.93%
B 1.80%
Below B 0.05%
    CCC 0.05%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.62%
Not Available 14.69%
Short Term 0.00%
As of October 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
59.25%
Materials
1.70%
Consumer Discretionary
4.05%
Financials
52.45%
Real Estate
1.05%
Sensitive
31.15%
Communication Services
1.99%
Energy
12.15%
Industrials
13.85%
Information Technology
3.17%
Defensive
8.88%
Consumer Staples
3.78%
Health Care
0.29%
Utilities
4.81%
Not Classified
0.72%
Non Classified Equity
0.29%
Not Classified - Non Equity
0.43%
As of October 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of October 31, 2025
Type % Net
Government 30.99%
Corporate 43.14%
Securitized 0.46%
Municipal 13.89%
Other 11.52%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.43%
Less than 1 Year
0.43%
Intermediate
66.61%
1 to 3 Years
5.62%
3 to 5 Years
13.05%
5 to 10 Years
47.94%
Long Term
32.56%
10 to 20 Years
7.47%
20 to 30 Years
13.39%
Over 30 Years
11.70%
Other
0.40%
As of October 31, 2025
View Bond Maturity Exposure
Start Trial